PDE4D Cell-Based Activity Assay Kit

Art Nr.: BPS-60505, BPS
Biomol GmbH
Waidmannstr. 35
Tel:+49-40 - 85 32 600
0800 - 24 66 651 free call
Fax: +49-40 - 85 32 60-22
0800 - 24 66 652 free call

PDE4D Cell-Based Activity Assay Kit

Catalog #: BPS-60505
Size: 500 reactions
The PDE4D cell-based activity assay is designed for screening inhibitors of PDE4D7 in cultured cells. The assay is based on transfecting cells with the CRE luciferase reporter. CRE reporter contains the firefly luciferase gene under the control of cAMP response element (CRE). Elevation of intracellular cAMP activates CRE binding protein (CREB) to bind CRE and induce the expression of luciferase. When cells transiently transfected with CRE reporter are activated by forskolin, the intracellular level of cAMP is upregulated, which induces the expression of CRE luciferase reporter. However, when cells are co-transfected with PDE4D7 expression vector and CRE reporter, the level of forskolin-induced cAMP is reduced, resulting in lower expression level of luciferase. When cells are treated with PDE4D inhibitor to inhibit PDE4D7 activity, cAMP level is restored, resulting in higher luciferase activity.
PDE4D, phosphodiesterase 4D
Supplied As:
The kit includes CRE luciferase reporter (premixed with constitutively-expressing Renilla(sea pansy) luciferase vector that serves as an internal control for transfection efficiency),PDE4D7 expression vector, and forskolin.
Instructions for use:
See assay kit data sheet for detailed protocol.
Storage / Stability:

Stable at least 6 months from date of receipt, when stored as directed (-20°C)

The kit is designed for screening inhibitors of PDE4D and for monitoring PDE4D/ cAMP signaling pathway activity.
1. Montminy MR et al. (1987). Nature 328(6126):175-1782. Fan Chung, K. (2006). Eur. J. Pharmacol. 533(1-3):110-1173. Malik, R. et al. (2008). Appl. Microbiol. Biotechnol. 77 (5): 1167-1173

This product is offered by Biomol for research purposes only. Not for diagnostic purposes or human use. It may not be resold or used to manufacture commercial products without written approval of Biomol GmbH.